Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Generated Narrative: Evidence 47695
version: 20; Last updated: 2023-12-06 17:43:24+0000
Profiles: ComparativeEvidence, SingleStudyEvidence
url: https://fevir.net/resources/Evidence/47695
identifier: FEvIR Object Identifier/47695
name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Mingrone_2015_DIBASY_trial
title: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2015 (DIBASY) trial
status: Active
date: 2022-05-29 11:07:10+0000
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
author: Brian S. Alper:
Code | Value[x] |
Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | ComparativeEvidence |
Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | SingleStudyEvidence |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
relatedArtifact
type: Derived From
label: data source
display: Figure 2C
citation:
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations [Journal Article]. Contributors: Francesco Rubino, David M Nathan, Robert H Eckel, Philip R Schauer, K George M M Alberti, Paul Z Zimmet, Stefano Del Prato, Linong Ji, Shaukat M Sadikot, William H Herman, Stephanie A Amiel, Lee M Kaplan, Gaspar Taroncher-Oldenburg, David E Cummings, Delegates of the 2nd Diabetes Surgery Summit. In: Diabetes care, PMID 27222544. Published June 2016. Available at: https://pubmed.ncbi.nlm.nih.gov/27222544/.
Documents
Url https://diabetesjournals.org/care/article/39/6/861/29305/Metabolic-Surgery-in-the-Treatment-Algorithm-for
relatedArtifact
type: Cite As
citation:
ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2015 (DIBASY) trial [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47695. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47695. Computable resource at: https://fevir.net/resources/Evidence/47695.
description:
Mean HbA1c at 60 months in Mingrone 2015 was 6.55% in Surgery group (n = 38) and 6.9% in Medical/Lifestyle group (n = 15), mean difference -0.35% (95% CI -0.69% to -0.01%)
variableDefinition
description:
53 patients aged 30-60 years with BMI of 35 or more and a history of T2DM lasting at least 5 years
variableRole: Population
variableDefinition
description:
Roux-en-Y gastric bypass or Biliopancreatic Diversion vs. medical treatment
variableRole: Exposure
comparatorCategory: medical treatment
observed: GroupAssignment: Roux-en-Y gastric bypass or Biliopancreatic Diversion vs. medical treatment
variableDefinition
description:
HbA1c at 60 months
variableRole: Outcome
observed: OutcomeVariable: HbA1c at 60 months
synthesisType: not applicable
studyDesign: randomized assignment
statistic
description:
mean difference -0.35% (95% CI -0.69% to -0.01%)
note: Mean HbA1c at 60 months in Mingrone 2015 was 6.55% in Surgery group (n = 38) and 6.9% in Medical/Lifestyle group (n = 15)
statisticType: Mean Difference
quantity: -0.35 % (Details: UCUM code% = '%')
SampleSizes
NumberOfParticipants KnownDataCount 53 53 AttributeEstimates
Description Type Level Range 95% CI -0.69% to -0.01%
Confidence interval 0.95 -0.69--0.01 %